Tech Company Financing Transactions
BioGenCell Funding Round
On 5/9/2022, BioGenCell raised $16 million in Seed funding from private investors.
Transaction Overview
Company Name
Announced On
5/9/2022
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Seed
Investors
private investors (Lead Investor) (Marius Nacht)
Proceeds Purpose
The company intends to use the funds to accelerate its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
16 Divrey Chaim St.
Netanya, 4244916
Israel
Netanya, 4244916
Israel
Phone
Website
Email Address
Overview
BioGenCell's mission is to develop its innovative technology platform enabling the rapid creation of easy-to-use, patient friendly and cost-effective treatments for a wide range of degenerative, life threatening vascular diseases, using highly standardised therapies derived from adult stem cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yael Porat
Chief Scientific Officer
Michael Belkin
Co-Founder
Eyal Peleg
Browse more venture capital transactions:
Prev: 5/9/2022: BlueWind Medical venture capital transaction
Next: 5/9/2022: Hugging Face venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs